W. Nikolaizik (Essen, Germany), A. Bush (London, UK)
Early signs of MMP/TIMP imbalance in cystic fibrosis
J. Braun, M. Hartog, J. Wermelt, K. Paul, K. Dalhoff, F. Ratjen (Lübeck, Berlin, Essen, Germany)
|  |
IL-10 induced T-cell tolerance to Aspergillus fumigatus and Pseudomonas aeruginosa in cystic fibrosis
C. Casaulta, M. H. Schoeni, R. Crameri, M. Jutel, I. Daigle, M. Akdis, K. Blaser, C. A. Akdis (Berne, Davos-Platz, Switzerland; Wroclav, Poland)
| |
Ionic composition of exhaled breath condenesate in cystic fibrosis
B. Balint, S. A. Kharitonov, M. Kemp, D. Geddes, M. E. Hodson, P. J. Barnes (London, United Kingdom)
| |
Nasal NO concentrations and colonization of lower airways with P. aeruginosa are associated with variants in the neuronal NO synthase (NOS1) gene in CF patients
S. Gärtig, F. Ratjen, W. H. Nikolaizik, R. Büscher, H. Grasemann (Essen, Germany)
| |
Severity of cystic fibrosis is associated with genpolymorphism of the glutathione-S-transferase and Mn-superoxide dismutase
C. Flamant, A. Clement, R. C. Strange, K. Chadelat, A. Henrion (Paris, France; Stoke-on-Trent, United Kingdom)
| |
S-nitrosoglutathione up-regulates mature form of CFTR through transcription factor SP1 in CFPAC-1 and BHK cells
K. Zaman, L. Palmer, G. Li, M. McPherson, J. Vaughan, J. Hunt, B. Gaston ()
| |
Topical application of gentamicin causes a reduction of sweat ion concentration in cystic fibrosis patients carrying nonsense mutations
L. Romano, R. Casciaro, P. Vanini, I. Negro, N. Minuto, S. Bellodi, D. Erba (Genova, Italy)
| |
Bacterial killing is enhanced after exogenous administration of lysozyme in the lungs
R. Epaud, H. T. Akinbi, C. Oka, M. Tanaka, T. E. Weaver (Paris, France; Cincinnati, United States Of America; Wakaba, Japan)
| |